# PRESS RELEASE 2024 # [Ferring bolsters global gene therapy supply chain with European manufacturing facility](/content/ferring-bolsters-global-gene-therapy-supply-chain-with-european-manufacturing-facility/index.html) By [celia](/content/author/celia/index.html) in [PRESS RELEASE 2024](/content/category/press-release-2024/index.html) on 03 October 2024 --- # [Ferring demonstrates effectiveness of a treat-to-target approach in mild-to-moderate ulcerative colitis in first major study](/content/ferring-demonstrates-effectiveness-of-a-treat-to-target-approach-in-mild-to-moderate-ulcerative-colitis-in-first-major-study/index.html) By [celia](/content/author/celia/index.html) in [PRESS RELEASE 2024](/content/category/press-release-2024/index.html) on 01 October 2024 Ferring demonstrates effectiveness of a treat-to-target approach in mild-to-moderate ulcerative colitis in… --- # [Dr. Michael Rosenblatt joins Ferring Pharmaceuticals’ Board of Directors](/content/dr-michael-rosenblatt-joins-ferring-pharmaceuticals-board-of-directors/index.html) By [celia](/content/author/celia/index.html) in [PRESS RELEASE 2024](/content/category/press-release-2024/index.html) on 23 July 2024 --- # [Ferring Pharmaceuticals successfully launches its third Swiss Franc Bond offering for CHF 330 million](/content/ferring-pharmaceuticals-successfully-launches-its-third-swiss-franc-bond-offering-for-chf-330-million/index.html) By [celia](/content/author/celia/index.html) in [PRESS RELEASE 2024](/content/category/press-release-2024/index.html) on 27 May 2024 Ad hoc announcement pursuant to Art. 53 LR Ferring Pharmaceuticals successfully launches… --- # [Ferring announces results demonstrating the efficacy and safety of follitropin delta for women undergoing in vitro fertilisation using an agonist protocol](/content/ferring-announces-results-demonstrating-the-efficacy-and-safety-of-follitropin-delta-for-women-undergoing-in-vitro-fertilisation-using-an-agonist-protocol/index.html) By [celia](/content/author/celia/index.html) in [PRESS RELEASE 2024](/content/category/press-release-2024/index.html) on 17 May 2024 Ferring announces results demonstrating the efficacy and safety of follitropin delta for… --- # [Ferring Pharmaceuticals and SK pharmteco enter into commercial gene therapy manufacturing deal](/content/ferring-pharmaceuticals-and-sk-pharmteco-enter-into-commercial-gene-therapy-manufacturing-deal/index.html) By [celia](/content/author/celia/index.html) in [PRESS RELEASE 2024](/content/category/press-release-2024/index.html) on 18 April 2024 Ferring Pharmaceuticals and SK pharmteco enter into commercial gene therapy manufacturing deal… --- # [Launch of two first-in-class medicines in 2023 marks start of exciting phase of growth for Ferring](/content/launch-of-two-first-in-class-medicines-in-2023-marks-start-of-exciting-phase-of-growth-for-ferring/index.html) By [celia](/content/author/celia/index.html) in [PRESS RELEASE 2024](/content/category/press-release-2024/index.html) on 09 April 2024 Launch of two first-in-class medicines in 2023 marks start of exciting phase… --- # [Ferring announces full availability of ADSTILADRIN® (nadofaragene firadenovec-vncg) in the U.S.](/content/ferring-announces-full-availability-of-adstiladrin-nadofaragene-firadenovec-vncg-in-the-u-s/index.html) By [celia](/content/author/celia/index.html) in [PRESS RELEASE 2024](/content/category/press-release-2024/index.html) on 16 January 2024 ---